AbbVie Inc. financial data

Symbol
ABBV on NYSE
Industry
Pharmaceutical Preparations
Location
1 North Waukegan Road, North Chicago, Illinois
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 3, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 91.5 % -0.58%
Quick Ratio 11.2 % -0.53%
Return On Equity 55.1 % +11.4%
Return On Assets 4.32 % -20.6%
Operating Margin 23.5 % -17.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.77 B shares +0.09%
Entity Public Float 236 B USD -12.2%
Weighted Average Number of Shares Outstanding, Basic 1.77 B shares -0.06%
Weighted Average Number of Shares Outstanding, Diluted 1.77 B shares -0.17%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 54.4 B USD -4.12%
Revenue from Contract with Customer, Excluding Assessed Tax 54.3 B USD -6.44%
Costs and Expenses 41.6 B USD +2.57%
Operating Income (Loss) 12.8 B USD -20.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7.53 B USD -16.5%
Income Tax Expense (Benefit) 1.53 B USD +6.71%
Net Income (Loss) Attributable to Parent 5.99 B USD -21%
Earnings Per Share, Basic 3.37 USD/shares -20.9%
Earnings Per Share, Diluted 3.37 USD/shares -20.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.1 B USD +169%
Accounts Receivable, after Allowance for Credit Loss, Current 11.9 B USD +4.15%
Inventory, Net 4.25 B USD +10.7%
Assets, Current 38.9 B USD +46.7%
Property, Plant and Equipment, Net 4.98 B USD +0.99%
Operating Lease, Right-of-Use Asset 744 M USD +0.95%
Intangible Assets, Net (Excluding Goodwill) 62.2 B USD -4.05%
Goodwill 33.4 B USD +3.74%
Other Assets, Noncurrent 9.07 B USD +56.3%
Assets 149 B USD +10.7%
Accounts Payable, Current 3.69 B USD +25.7%
Employee-related Liabilities, Current 1.8 B USD +31.4%
Liabilities, Current 41.5 B USD +50.5%
Long-term Debt and Lease Obligation 63.8 B USD +7.61%
Accrued Income Taxes, Noncurrent 2.18 B USD -26.9%
Deferred Income Tax Liabilities, Net 2.72 B USD +29%
Operating Lease, Liability, Noncurrent 735 M USD -2.52%
Other Liabilities, Noncurrent 32.8 B USD +1.64%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.45 B USD -9.95%
Retained Earnings (Accumulated Deficit) -2.38 B USD -200%
Stockholders' Equity Attributable to Parent 8.01 B USD -39.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 8.05 B USD -39.5%
Liabilities and Equity 149 B USD +10.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.04 B USD -3.65%
Net Cash Provided by (Used in) Financing Activities 10.8 B USD
Net Cash Provided by (Used in) Investing Activities -9.59 B USD -1821%
Common Stock, Shares Authorized 4 B shares 0%
Common Stock, Shares, Issued 1.83 B shares +0.49%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.25 B USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 18.1 B USD +169%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.47 B USD -3.02%
Deferred Tax Assets, Valuation Allowance 13.5 B USD +40%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 19.9 B USD +31.5%
Operating Lease, Liability 901 M USD -2.07%
Depreciation 756 M USD -0.4%
Payments to Acquire Property, Plant, and Equipment 193 M USD +10.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.77 B USD -30.8%
Lessee, Operating Lease, Liability, to be Paid 1.01 B USD -2.23%
Property, Plant and Equipment, Gross 11.7 B USD +5.23%
Operating Lease, Liability, Current 166 M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 169 M USD +11.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -389 M USD -45.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 107 M USD -3.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 145 M USD +11.5%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -2.32 B USD -53.7%
Current Income Tax Expense (Benefit) 4.27 B USD +19.7%
Preferred Stock, Shares Authorized 200 M shares 0%
Unrecognized Tax Benefits 5.76 B USD +1.62%
Lessee, Operating Lease, Liability, to be Paid, Year Four 115 M USD +1.77%
Operating Lease, Payments 214 M USD +0.94%
Current Federal Tax Expense (Benefit) 3.27 B USD +23.6%
Amortization of Intangible Assets 7.89 B USD +1.38%
Deferred Tax Assets, Net of Valuation Allowance 6.46 B USD +16.7%
Share-based Payment Arrangement, Expense 782 M USD +15.3%
Interest Expense 2.33 B USD +4.3%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%